The article announces that GVK Biosciences has signed a deal with Indiana Clinical and Translational Sciences Institute (CTSI) and with the Biomarker Qualification Group of the U.S. Food and Drug Administration (FDA) to make its 13,000-biomarker database available for U.S. researchers.